News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
242 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
Aflac Names Bradley L. Knox as SVP and Counsel, Federal Relations
In this role, he will continue to represent Aflac in legislative and regulatory matters with the federal government by providing policy direction, coordinating federal affairs initiatives and lobbying for the company’s interests in Washington, D.C.
February 4, 2019
·
6 min read
Ncardia Launches iPSC-Based Phenotypic Screening Service to Bring Human Disease Biology Earlier into Drug Discovery and Development
The new service enables researchers to access human disease-relevant biology earlier in the drug discovery process with the goal of bringing better medicines to patients faster.
February 4, 2019
·
2 min read
Business
The Christ Hospital Adds World Renowned Cardiac Specialist to Region’s Premier Heart Program
The Christ Hospital Health Network is honoring its commitment to providing the best heart care in Greater Cincinnati with the addition of world-renowned clinician, Timothy Henry, M.D., FACC, MSCAI.
February 4, 2019
·
4 min read
Policy
APhA Issues Revised Guidelines for Pharmacy-based Immunization Advocacy and Administration
As the pharmacist role in raising the rate of immunizations continues to expand, the American Pharmacists Association has revised its Guidelines for Pharmacy-based Immunization Advocacy and Administration.
February 4, 2019
·
2 min read
Business
NMS Labs’ Pierre Cassigneul, President and Chief Executive Officer, Announces Membership into Vidocq Society
NMS Labs is well known nationally and internationally with over 3000 Police Departments, Prosecutors, Medical Examiners, Medico legal Death Investigators and other Federal and State Law Enforcement organizations who regularly send cases to our laboratory.
February 4, 2019
·
1 min read
Business
American Renal Associates® Opens Newest Dallas Area Clinic
American Renal Associates, LLC, a national provider of outpatient dialysis services, announced the opening of its newest clinic, Hunt County Dialysis Center, located at 3301 Ridgecrest Rd., Suite 1, Greenville, Texas.
February 4, 2019
·
2 min read
Deals
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) on February 1, 2019
Verastem, Inc. announced the grant of options to purchase 46,000 shares of its common stock to six new employees.
February 4, 2019
·
1 min read
Business
Gilead Sciences Announces 11 Percent Increase in First Quarter 2019 Dividend
Gilead Sciences, Inc. announced that the company’s Board of Directors has declared an increase of 11% in the company’s quarterly cash dividend, beginning in the first quarter of 2019.
February 4, 2019
·
1 min read
Business
Atlas Lift Tech Widens Their Footprint, Moving to the Texas Market, Launches Widely Across Baptist Health System Facilities
Baptist Heath System recognizes the importance of their care staff and patients by providing facilities within their system with vital Safe Patient Handling and Mobility resource Atlas Lift Tech.
February 4, 2019
·
3 min read
Deals
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) on January 31, 2019
Akebia Therapeutics, Inc. granted 11 newly-hired employees options to purchase an aggregate of 41,900 shares of Akebia’s common stock on January 31, 2019, as inducements material to each such employee’s entering into employment with Akebia.
February 4, 2019
·
1 min read
Previous
16 of 25
Next